|
SMEK2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.84369999951018E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.95080004664561E-09 |
| Normal-vs-Stage2 |
1.621400E-01 |
| Normal-vs-Stage3 |
6.293200E-01 |
| Normal-vs-Stage4 |
8.045600E-01 |
| Stage1-vs-Stage2 |
8.932000E-02 |
| Stage1-vs-Stage3 |
1.183190E-03 |
| Stage1-vs-Stage4 |
1.494570E-01 |
| Stage2-vs-Stage3 |
3.951600E-01 |
| Stage2-vs-Stage4 |
4.212400E-01 |
| Stage3-vs-Stage4 |
6.844400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.08039999963717E-07 |
| Normal-vs-AfricanAmerican |
6.641700E-04 |
| Normal-vs-Asian |
6.895200E-01 |
| Caucasian-vs-AfricanAmerican |
5.948800E-01 |
| Caucasian-vs-Asian |
3.731200E-01 |
| AfricanAmerican-vs-Asian |
4.322400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.27600000144579E-08 |
| Normal-vs-Female |
2.165600E-02 |
| Male-vs-Female |
2.233600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.941000E-03 |
| Normal-vs-Extreme_Weight |
2.20800000505506E-08 |
| Normal-vs-Obese |
3.657900E-02 |
| Normal-vs-Extreme_Obese |
1.673390E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.641400E-01 |
| Normal_Weight-vs-Obese |
2.545600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.135600E-01 |
| Extreme_Weight-vs-Obese |
6.918600E-03 |
| Extreme_Weight-vs-Extreme_Obese |
2.549800E-01 |
| Obese-vs-Extreme_Obese |
7.594400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.561400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.083000E-03 |
| Normal-vs-Age(61-80Yrs) |
1.39269999976932E-08 |
| Normal-vs-Age(81-100Yrs) |
1.960360E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.253800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.108750E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.802770E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.162700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.898580E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.014400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.41780004298187E-09 |
| Normal-VS-Type2 PRCC |
3.247600E-02 |
| Normal-VS-KIRP CIMP |
5.647400E-01 |
| Normal-VS-Unclassified PRCC |
5.270200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.720000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.021050E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.356830E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.679430E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.033200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.223850E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.00530000000044E-05 |
| Normal-vs-N1 |
2.346400E-01 |
| Normal-vs-N2 |
5.155800E-01 |
| N0-vs-N1 |
2.675800E-03 |
| N0-vs-N2 |
5.327200E-01 |
| N1-vs-N2 |
3.377600E-01 |
|
|
